MANILA - The Board of Investments (BOI) aims to attract more investments in the field of biotechnology as a Philippine delegation is meeting with healthcare innovators in the San Francisco Bay Area and Silicon Valley in a roadshow in the United States this week. The BOI, under its Make It Happen in the Philippines campaign, is doing a roadshow in Florida, San Francisco, and Los Angeles until Saturday to introduce opportunities in the country for US-based startups in the life sciences and healthcare space. DTI Undersecretary Rafaelita Aldaba is leading the delegation. Among the prominent startups that the delegation met during the roadshow include Filipino-led InterVenn Biosciences, Presidio Medical, and Vator. InterVenn, which was founded by Filipino Aldo Carrascoso, is pioneering the latest innovation in pre-cancer screening using artificial intelligence (AI). The company is further expanding its Philippine office, the hub for InterVenn's software, adding 100 software Filipino eng
Patricia B. Mirasol
InterVenn BioSciences recently raised US$34 million for the commercialization of a minimally invasive blood test for the early detection of ovarian cancer. The San Francisco-based healthtech company innovating on early cancer detection was co-founded by Filipino Aldo Carrascoso (pictured). Image via InterVenn BioSciences
InterVenn Biosciences, a San Francisco-based healthtech company innovating on early cancer detection, was co-founded by Filipino Aldo Carrascoso, who previously founded digital media platform Jukin Media and blockchain payment system Veem.
InterVenn recently raised US$34 million in Series B funding, led by Anzu Partners and participated in by Genoa Ventures, Amplify Partners, True Ventures, Xeraya Capital, and the Ojjeh family (of McLaren Group fame).